Ocular Therapeutix, Inc. (OCUL)
9.05
-0.11
(-1.20%)
USD |
NASDAQ |
Feb 12, 16:00
9.18
+0.13
(+1.44%)
After-Hours: 20:00
Ocular Therapeutix Free Cash Flow : -216.89M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Boston Scientific Corp. | 3.824B |
| Alnylam Pharmaceuticals, Inc. | 221.36M |
| Vertex Pharmaceuticals, Inc. | 3.337B |
| Bristol Myers Squibb Co. | 15.30B |
| Krystal Biotech, Inc. | 165.59M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -54.25M |
| Cash from Investing (Quarterly) | -2.839M |
| Cash from Financing (Quarterly) | 449.38M |
| Free Cash Flow Per Share (Quarterly) | -0.2561 |
| Free Cash Flow to Equity (Quarterly) | -57.05M |
| Free Cash Flow to Firm (Quarterly) | -54.26M |
| Free Cash Flow Yield | -12.80% |